Free Trial

California Public Employees Retirement System Sells 257,299 Shares of Humana Inc. (NYSE:HUM)

Humana logo with Medical background
Remove Ads

California Public Employees Retirement System trimmed its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 56.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 200,352 shares of the insurance provider's stock after selling 257,299 shares during the quarter. California Public Employees Retirement System owned approximately 0.17% of Humana worth $50,831,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. lifted its stake in Humana by 15.8% during the fourth quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock worth $3,254,899,000 after purchasing an additional 1,751,857 shares during the last quarter. Norges Bank bought a new position in shares of Humana in the 4th quarter worth about $416,202,000. Pzena Investment Management LLC boosted its holdings in shares of Humana by 44.0% in the 4th quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock valued at $915,736,000 after buying an additional 1,103,132 shares during the period. Boston Partners lifted its holdings in Humana by 435.8% in the fourth quarter. Boston Partners now owns 1,098,702 shares of the insurance provider's stock worth $279,236,000 after acquiring an additional 893,637 shares during the last quarter. Finally, Artisan Partners Limited Partnership raised its position in shares of Humana by 83.4% during the 4th quarter. Artisan Partners Limited Partnership now owns 673,715 shares of the insurance provider's stock worth $170,928,000 after purchasing an additional 306,433 shares during the period. 92.38% of the stock is owned by institutional investors.

Remove Ads

Analysts Set New Price Targets

A number of research firms recently weighed in on HUM. Barclays increased their price objective on shares of Humana from $255.00 to $270.00 and gave the stock an "equal weight" rating in a report on Thursday, February 13th. Piper Sandler lifted their target price on Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a research note on Wednesday, January 15th. JPMorgan Chase & Co. lowered their price target on Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a report on Tuesday, February 18th. Morgan Stanley decreased their target price on shares of Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a research report on Wednesday, February 12th. Finally, Truist Financial increased their price objective on shares of Humana from $260.00 to $290.00 and gave the company a "hold" rating in a report on Monday, January 6th. Eighteen analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, Humana currently has an average rating of "Hold" and an average target price of $285.68.

View Our Latest Stock Report on Humana

Humana Stock Performance

HUM traded down $1.13 during trading on Thursday, reaching $264.67. 1,808,672 shares of the company's stock were exchanged, compared to its average volume of 1,718,490. The company has a market capitalization of $31.94 billion, a P/E ratio of 26.60, a PEG ratio of 2.05 and a beta of 0.62. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The business has a 50 day moving average price of $268.40 and a 200 day moving average price of $272.56. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46.

Humana (NYSE:HUM - Get Free Report) last issued its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.34%. The ex-dividend date is Friday, March 28th. Humana's dividend payout ratio is currently 35.58%.

About Humana

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Stories

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Should You Invest $1,000 in Humana Right Now?

Before you consider Humana, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.

While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Best ETFs for Spring 2025: Strong and Steady Investing

Best ETFs for Spring 2025: Strong and Steady Investing

Whether you're after broad market exposure, dividend income, bonds, or even gold, we've got picks that can help you navigate the current investing landscape.

Related Videos

Massive Buybacks: 3 Stocks Insiders Are Buying Up
Volatility-Proof Your Portfolio with These 7 ETFs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads